EUVIMEDDescubrir EUVIMED
Open access · CC BY 4.0

Prevalence of Pre‐Clinical Obesity Among US Adults Receiving Medical and Surgical Obesity Treatment

Jason M Samuels iD, Emma Holler, Matthew D Spann, C Joe Northup, Tarik K Yuce

Obesity · 2026

DOI: 10.1002/oby.70171 ↗

At a glance

Journal article in Obesity, 2026. Written by Jason M Samuels and 4 co-authors. Institution: Department of General Surgery, Section of Surgical Sciences, Vanderbilt University Medical Center, Nashville, Tennessee, USA. Major MEDLINE topics: Obesity, Bariatric Surgery, Anti-Obesity Agents. Cited 3 times so far (Crossref); 21 references. The full text is freely available (open access, CC BY 4.0). Funded by: NIDDK NIH HHS, NCATS NIH HHS, National Institute of Diabetes and Digestive and Kidney Diseases.

ResumenSubjectsDatos bibliográficosCiteRelated studies

Abstract (original language)

Objective

We sought to determine how the proportion of adults historically receiving obesity interventions would be classified under the recently proposed “pre‐clinical” and “clinical” obesity classifications and the impact of this change on safety and outcomes.

Methods

A retrospective analysis of adults with BMI ≥ 35 who received bariatric surgery (BS) or antiobesity medications (AOMs) between 2017 and 2023 was conducted using the Merative MarketScan database. Patients had ≥ 6‐month continuous enrollment before treatment. Clinical obesity was defined as presence of ≥ 1 obesity‐related condition and pre‐clinical obesity defined as absence of such. Treatment‐related complications were identified within 90 days of treatment initiation. Multivariable logistic regression was used to compare the odds of treatment‐related complications by obesity classification.

Results

A total of 120,499 individuals (46.1%) underwent BS and 140,909 (53.9%) received AOMs. Among BS patients, 12.7% ( n = 15,334) had pre‐clinical obesity. Of AOM users, 38.1% ( n = 53,633) had pre‐clinical obesity. Clinical obesity patients were older with a higher comorbidity burden compared to pre‐clinical obesity. Clinical obesity was associated with higher odds of post‐treatment complications (AOM: aOR 1.10, BS: aOR 1.39, both p < 0.001).

Conclusions

This novel framework would reclassify a significant proportion of patients as having pre‐clinical obesity. Use of these definitions to determine treatment eligibility could potentially delay intervention and shift care to older, sicker populations.

Subjects

MeSH terms (MEDLINE)

ObesityBariatric SurgeryAnti-Obesity AgentsHumansFemaleRetrospective StudiesMaleAdultMiddle AgedUnited StatesPrevalenceBody Mass IndexLogistic ModelsComorbidity

Author keywords

bariatric surgeryclinical obesitylancet commissionobesity medicationspre‐clinical obesity

Substances

Anti-Obesity Agents

Authors and institutions

  • Department of General Surgery, Section of Surgical Sciences, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
  • Surgical Outcomes and Quality Improvement Center (SOQIC), Department of Surgery, Indiana University School of Medicine, Indianapolis, Indiana, USA.

ORCID profiles: Jason M Samuels

Funding

  • NIDDK NIH HHS
  • NCATS NIH HHS
  • National Institute of Diabetes and Digestive and Kidney Diseases
  • National Center for Advancing Translational Sciences

Cite

APA

Samuels, J. M., Holler, E., Spann, M. D., Northup, C. J., & Yuce, T. K. (2026). Prevalence of Pre‐Clinical Obesity Among US Adults Receiving Medical and Surgical Obesity Treatment. Obesity. https://doi.org/10.1002/oby.70171

Vancouver

Samuels JM, Holler E, Spann MD, Northup CJ, Yuce TK. Prevalence of Pre‐Clinical Obesity Among US Adults Receiving Medical and Surgical Obesity Treatment. Obesity. 2026. doi:10.1002/oby.70171

BibTeX
@article{Samuels2026,
  author = {Samuels, Jason M and Holler, Emma and Spann, Matthew D and Northup, C Joe and Yuce, Tarik K},
  title = {Prevalence of Pre‐Clinical Obesity Among US Adults Receiving Medical and Surgical Obesity Treatment},
  journal = {Obesity},
  year = {2026},
  doi = {10.1002/oby.70171}
}
Start for free →